elvitegravir Articles

US FDA delays approval of Gilead's elvitegravir and cobicistat for HIV

30 April 2013

Japan Tobacco files for Japanese approval of elvitegravir

11 December 2012

Batch of clinical trial results for Gilead's elvitegravir, Complera and cobicistat

25 July 2012

Gilead files elvitegravir and cobicistat with FDA; AHF plea on Quad pricing

29 June 2012

Ranbaxy and Mylan unit to make and market three Gilead HIV drugs in developing countries

13 July 2011

Gilead to boost HIV/hep B drug access via link with Medicine Patent Pool

12 July 2011

Gilead’s investigational antiviral elvitegravir meets 48-week primary goal

24 March 2011

Showing 1-7 of 7 articles

Go to beginningPrevious
  • 1
NextGo to end